Medicare Enrolled
Dr. Paul Guichard, DO
Cardiovascular Disease · Marietta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Guichard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guichard?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Guichard
Dr. Paul Guichard is a cardiovascular disease specialist in Marietta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Guichard performed 1,855 Medicare services across 1,540 unique beneficiaries.
Between the years covered by Open Payments, Dr. Guichard received a total of $220,738 from 41 pharmaceutical and/or device companies across 624 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Guichard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ 1,855 Medicare services
$220,738 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,855
Medicare services
Bottom 48% in GA for cardiovascular disease
1,540
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~93 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
558 | $91 | $282 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
290 | $11 | $58 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
125 | $9 | $128 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
118 | $6 | $26 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
116 | $93 | $260 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
107 | $51 | $233 |
| Cardiac catheterization | 70 | $186 | $818 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
61 | $4 | $20 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
55 | $11 | $46 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
47 | $16 | $58 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $107 | $372 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
44 | $399 | $1,727 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
33 | $60 | $259 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 29 | $258 | $1,006 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
29 | $133 | $450 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
24 | $75 | $240 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
18 | $15 | $51 |
| Right heart catheterization A procedure where a thin, flexible tube is inserted into the right side of the heart to measure pressure and oxygen levels. |
17 | $100 | $391 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
16 | $56 | $240 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
15 | $19 | $94 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $134 | $388 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $198 | $909 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
12 | $64 | $184 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.5% high complexity
10.2% medium
76.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$220,738
Total received (2018-2024)
Avg $31,534/year across 7 years
Top 2% in GA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
624
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$210,638 (95.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,100 (4.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$47,597
2023
$36,391
2022
$30,048
2021
$15,200
2020
$16,794
2019
$46,232
2018
$28,476
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
United Therapeutics Corporation
$23,991
Actelion Pharmaceuticals US, Inc.
$15,537
Merck Sharp & Dohme LLC
$3,599
Bayer Healthcare Pharmaceuticals Inc.
$2,820
Inari Medical, Inc.
$467
Medtronic, Inc.
$217
Penumbra, Inc.
$149
PFIZER INC.
$147
Edwards Lifesciences Corporation
$121
AngioDynamics, Inc.
$95
Boston Scientific Corporation
$94
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$79
Novo Nordisk Inc
$69
AstraZeneca Pharmaceuticals LP
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
Kiniksa Pharmaceuticals International, plc
$39
SCPHARMACEUTICALS INC.
$30
CARDIVA MEDICAL, INC.
$23
Top 3 companies account for 90.6% of 2024 payments
All-time payments by company (2018-2024) ›
Actelion Pharmaceuticals US, Inc.
$83,202
United Therapeutics Corporation
$83,046
Bayer HealthCare Pharmaceuticals Inc.
$37,380
Merck Sharp & Dohme LLC
$3,659
Bayer Healthcare Pharmaceuticals Inc.
$3,569
Penumbra, Inc.
$2,848
Inari Medical, Inc.
$1,144
Novartis Pharmaceuticals Corporation
$749
Boston Scientific Corporation
$593
ABIOMED
$489
PFIZER INC.
$453
Medtronic, Inc.
$378
AngioDynamics, Inc.
$329
Edwards Lifesciences Corporation
$318
AstraZeneca Pharmaceuticals LP
$301
EKOS Corporation
$270
Janssen Pharmaceuticals, Inc
$194
Amgen Inc.
$193
Gilead Sciences, Inc.
$178
W. L. Gore & Associates, Inc.
$150
Abbott Laboratories
$144
BOSTON SCIENTIFIC CORPORATION
$141
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$136
Novo Nordisk Inc
$126
E.R. Squibb & Sons, L.L.C.
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
Medtronic Vascular, Inc.
$101
Shockwave Medical, Inc
$77
SANOFI-AVENTIS U.S. LLC
$62
Kiniksa Pharmaceuticals International, plc
$39
Esperion Therapeutics, Inc.
$33
SCPHARMACEUTICALS INC.
$30
Lantheus Medical Imaging, Inc.
$27
Impulse Dynamics (USA) Inc.
$26
CARDIVA MEDICAL, INC.
$23
Sandoz Inc.
$22
Philips Electronics North America Corporation
$19
Regeneron Healthcare Solutions, Inc.
$19
Lundbeck LLC
$19
Alnylam Pharmaceuticals Inc.
$15
BIOTRONIK INC.
$12
Top 3 companies account for 92.2% of all-time payments
Associated products mentioned in payments ›
(9520) IGT Devices Und · ALPHAVAC · AVVIGO Guidance System · Adempas · AngioVac · Arcalyst · BRILINTA · CARDIOFORM Septal Occluder · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CoreValve Evolut · Corlanor · DEFINITY · EKOSONIC · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Ensite Cardiac Mapping System · FLOWTRIEVER CATHETER · FUROSCIX · FlowTriever · GENERAL VASCULAR INTERVENTION · GORE CARDIOFORM Septal Occluder · General - Vascular Intervention · Impella · Indigo System · JARDIANCE · Kerendia · LEQVIO · LifeVest · NEXLETOL · NORTHERA · ONGLYZA · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · REMODULIN · RESOLUTE ONYX · RYBELSUS · Repatha · Resolute · Rybelsus · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYMPLICITY G3 · TREPROSTINIL · TYVASO · Telescope · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · Vascular Lithotripsy · WATCHMAN · WINREVAIR · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for cardiovascular disease in GA.
Geographic Context
Cardiologists within 10 mi
280
Per 100K population
36.4
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Guichard is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Guichard experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Guichard performed 558 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Guichard receive payments from pharmaceutical companies?
Yes. Dr. Guichard received a total of $220,738 from 41 companies across 624 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Guichard's costs compare to other cardiologists in Marietta?
Dr. Guichard's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Guichard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Marietta
Browse cardiologists in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in GA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in GA
Which GA cardiologists receive the most from drug and device companies.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
By company
United Therapeutics Corporation Payments to Doctors
See all physicians who received payments from United Therapeutics Corporation.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology